1405-9940

S1405-99402022000500001

10.24875/acm.m22000081

México

USA

México

00 00 2022

92 1 62

2019 74 20 20

2529-32

2017 70 1 1

1-25

2020 36 3 3

390-413

2019 45 4 4

1990-2015

2020

2002 44 6 6

546-53

2021 19 9 9

2014

221-37

2017 1.ªedición

168

2020 41 1 1

111-88

2019 139

1082-143

2012 74 4 4

614-20

2014 13 5 5

274-7

2015 14 2 2

103-6

1999 318 7183 7183

593-6

2012 7 1 1

1-7

2015 6 6 6

329-34

Institute of Medicine

Scottish Intercollegiate Guidelines Network

2019 61 3 3

359-414

2021 7 1 1

318-2020

AGREE Next Steps Consortium

2016 352

i1152

2017 358

1-8

2018 18 1 1

101-8

2014 12 12 12

1495-9

2015 61 12 12

1446-52

Colegio Mexicano de Inmunología Clínica y Alergia, Sociedad Latinoamericana de Alergia, Asma e Inmunología

2017 64 supl 1 supl 1

2019 78 supl 1 supl 1

4-76

2018 65

8-88

2006 3 2 2

90-5

1987 4 3 3

205-14

2017 17 1 1

1-10

1971 75 3 3

471-2

World Health Organization

2007

1995 92 5 5

1355-74

2020 15 1 1

1-16

2019 18 7 7

534-44

2015 3 5 5

339-55

1999 100 13 13

1481-92

2003 18 12 12

1039-52

2019 7 10 10

e1332-45

2012 28 10 10

1667-76

2017 5 3 3

196-213

2021 288 12 12

3727-45

2020 105 12 12

dgaa674

2017 11 2 2

157-68

2004 164

1285-92

2017 87 4 4

292-301

SCORE2 working group and ESC Cardiovascular risk collaboration

2021 42 25 25

2439-54

2017 3 3 3

CD009868

2014 160

468-76

2017 3 3 3

CD006887

2016 316 12 12

1289-97

2016 37 39 39

2999-3058

2018 7 7 7

CD012345

2013 12 12

CD002128

2012 2012 4 4

CD009825

2011 7 7

CD002137

2021 10 2 2

1-19

2019 109 1 1

7-16

2018 119 1 1

96-108

2017 75 9 9

683-98

2017 8 8 8

CD005051

2016 116 8 8

1369-82

2021 13 5 5

1-15

2021 13 3 3

1-11

Department of Health &Human Services 2018

2014 2014 8 8

CD009387

2020 324 20 20

2076-94

2019 16 6 6

477-91

2018 10 11 11

1577

2018 24 3 3

220-30

2018 101

9-20

2018 2018

5982980

2016 10 5 5

589-602

2014 129 25 Suppl 1 25 Suppl 1

102-38

2014 129 25 Suppl 1 25 Suppl 1

76-99

2016 115 3 3

466-79

2013 113 12 12

1640-61

U.S. Department of Health and Human Services 2014

2018 94

203-33

2003 37 4 4

283-90

2010 376 9753 9753

1670-81

2016 316 19 19

2008-24

2020 2020

3987065

2019 171 1 1

73-4

2015 2015 3 3

CD008226

2015 2015 3 3

CD008226

2020 6 6 6

CD012735

2019 98 6 6

2018 25 8 8

844-53

2018 97 50 50

2018 3 9 9

823-8

American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health;Council on Cardiovascular Disease in the Young;Council on Clinical Cardiology;and Stroke Council

2019 39 2 2

e38-81

2018 11 11 11

CD012502

2020 19 1 1

1-7

2020 20 3 3

239-48

2019 12 8 8

1-13

100

2019 139

1144-61

101

2021 12 2 2

98-108

102

2018 8 1 1

1-9

103

2015 201

247-52

104

2015 38 12 12

763-9

105

2018 60 2 2

229-39

106

2020 133 11 11

1322-7

107

2017 227

850-7

108

2016 23 1 1

35-41

109

2016 23

4-26

110

2020 10 10 10

CD011748

111

2021 773

397-407

112

2021 19 4 4

390-7

113

2020 19 2 2

759-65

114

2020 37 4 4

1496-521

115

2019 42 9 9

1029-39

116

2019

117

2020 22

E64-7

118

2017 376 18 18

1713-22

119

2018 379 22 22

2097-107

120

2017 17 4 4

299-309

121

2019 79 7 7

751-66

122

2015 9 2 2

217-25

123

2014 14 5 5

367-76

124

2015 2015 10 10

CD009580

125

2018 8 11 11

1-9

126

2021 16 2 2

127

2016 10 4 4

905-14

128

2015 65

23-30

129

2021 41 1 1

19-28

130

2020 21 1 1

131

2020 19 1 1

128

132

2020 9 15 15

133

2020 75 11 11

1987

134

Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP)

2020 17 7 7

135

2018 18 4 4

271-82

136

2020 134

69-73

137

2020 313

76-80

138

2020 22 5 5

139

2015 385 9976 9976

1397-405

140

2019 71 9 9

1221-9

141

2012 12 Suppl.3 Suppl.3

26-32

142

2021 28 3 3

274-83

143

2017 35 8 8

1546-53

144

1994 14

840-46

145

2014 129 25 Suppl 2 25 Suppl 2

S1-45